tanzania-sea-beach-zanzibar-paradise-africa-sand-3692068

WHO confirm Tanzania FDA as Africa’s first well-functioning regulatory body

December 11, 2018
Manufacturing and Production Africa, TFDA, Tanzania, WHO, regulation, regulatory

Tanzania has become the first country in Africa to achieve a well-functioning regulatory system for medical products, according to the …

Generics firms investigated for their involvement in the ‘largest cartel in the history of the United States’

December 11, 2018
Manufacturing and Production Dr Reddy's, Mylan, Teva, US, corruption, generics, price fixing, price-fixing, sun

At least 16 generic drugmakers are being investigated for their involvement in what has been described as the “largest cartel …

ben_osborne

Pfizer announces new UK Managing Director

December 10, 2018
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Ben Osborne, EU, Leeds, Pfizer, sales

New York City-based multinational Pfizer has announced the appointment of Ben Osborn to the role of managing Director in the …

maps-2018-01-boulder-staged-lana-marcela-bruce-bryce-img_20180128_135008_preview

Psychedelic therapy: A new approach to mental health

December 10, 2018
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing LSD, MDMA, controlled substances, depression, mental health, pharma, psychotherapy

In November 2018, a Phase 2 clinical trial found that 76% of patients who underwent MDMA-assisted psychotherapy no longer had …

shutterstock_273326141

AstraZeneca partners up with CRUK for new UK cancer drug discovery facility

December 10, 2018
Research and Development, Sales and Marketing AstraZeneca, CRUK, Cancer, pharma

AstraZeneca is to team up with Cancer Research UK to build a new centre of excellence for accelerating the discovery …

boites_de_xanax_et_dalprazolam_en_ce_moment_dans_les_pharmacies

Children being treated for problems with Xanax has increased more than 6 times since last year

December 10, 2018
Research and Development, Sales and Marketing UK, drug abuse, misuse, prescriptions, valium, xanax

The number of children being treated for problems with benzodiazepine drugs – which include prescription medicines Xanax and Valium – …

1920px-hiv-budding-color

Trump administration block NIH researchers from using foetal tissue, disrupting research to cure HIV

December 10, 2018
Sales and Marketing HIV, Trump, US government, feotal tissue, mice, research

The Trump Administration has halted the acquisition of new human foetal tissue for use in experiments conducted by NIH researchers, …

Gilead names Roche veteran Daniel O’Day as new CEO

December 10, 2018
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing CEO, Gilead, Roche, appointment

Almost half a year since it was revealed that Gilead’s Dr John Milligan would be stepping down from his role …

bad_homburg_fresenius_zentrale

Akorn CEO resigns after $4.3bn Fresenius deal falls through

December 10, 2018
Sales and Marketing Akorn, CEO, Fresenius, M&A, MA, Raj Rai, court, generics

The CEO of American generics firm Akorn Inc has stepped down following a ruling from the Delaware Supreme Court declaring …

top_10_image

Top Ten most popular articles on Pharmafile.com this week!

December 7, 2018
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Bayer, Cancer, Diagnostics, Sanofi, Takeda, brexit

Takeda’s acquisition of Shire finally got the go-ahead this week as 88% of shareholders voted in favour of French CEO …

28246711066_52e38bc591_z

Health Secretary Matt Hancock says government may charter flights to deliver medicines in case of no-deal Brexit

December 7, 2018
Medical Communications Matt Hancock, NHS, UK, brexit, no-deal

British health secretary Matt Hancock has said the government is working out ways through which they could charter flights in …

gilead-sciences

NICE give go-ahead to Gilead’s Yescarta for adults with lymphoma

December 7, 2018
Medical Communications Cancer, Cost, Gilead, NHS, NICE, Yescarta, access

The NHS cost effectiveness body NICE has approved Gilead’s Yescarta for treatment of come adults with lymphoma. Gilead’s treatment will …

gehrynovartis

Novartis CEO calls for cultural shift to cater for millennial generation

December 7, 2018
Medical Communications Business, company, culture, millenials. Novartis

The CEO of Swiss multinational Novartis has said that he wants to ‘un-boss’ the multi-billion pound company while relaxing the …

AstraZeneca

AstraZeneca’s head and neck cancer treatment Imfinzi falls flat in Phase III trials

December 7, 2018
Medical Communications AstraZeneca, Cancer, oncology, phase III, treatment

AstraZeneca’s immunotherapy treatment Imfinzi has failed to meet its primary goal in treating head and neck cancer in the Phase …

jeffrey_hackman

EUSA Pharma take on Novelion CEO Jeffrey Hackman to lead US expansion

December 6, 2018
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

The Hertfordshire-based speciality pharma firm EUSA Pharma has appointed Jeffrey S Hackman as President of the company’s United States operations. …

UCB to invest £1 billion into UK R&D

December 6, 2018
Manufacturing and Production, Research and Development R&D, UCB, UK, brussels, investment, research

The Brussels-based multinational UCB will invest £1 billion into UK research and development, according to the government’s Life Sciences Sector …

British researchers sequences 100,000 whole genomes

December 6, 2018
Research and Development Matt Hancock, digital, genome, personalised medicnie

British researchers have sequenced 100,000 whole genomes as part of an effort to improve understanding of rare diseases and move …

Bayer to cut 12,000 jobs by 2025

December 6, 2018
Business Services, Manufacturing and Production, Sales and Marketing Bayer, Germany, Jobs, manfucaturing, monsanto, production

German pharma giant Bayer is set to cut 12,000 jobs by 2025 as part of a plan to focus on …

Takeda shareholders approve $62bn Shire acquisition

December 6, 2018
Business Services Ireland, Japan, M&A, MA, Shire, Takeda, acquisition

Japanese firm Takeda have gained shareholders’ approval for the $62 billion acquisition of the Irish headquartered company Shire Plc. The …

Sanofi announce cull of 670 French jobs

December 6, 2018
Business Services, Manufacturing and Production CGT, France, Jobs, Macron, Sanofi, gilet jaunes, yellow jackets

French pharma giant Sanofi has said that it will cut 670 jobs in France over the next two years. The …

The Gateway to Local Adoption Series

Latest content